Acasă › Cancer pulmonar cu celule non-pătrate › Illinois › Cicero
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Cicero, IL
24 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Cicero (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
În curs de recrutareFaza 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · La 10 mi distanță
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- Edward Hines Jr VA Hospital, Hines · La 4 mi distanță
- Advocate Christ Medical Center, Oak Lawn · La 9 mi distanță
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
În curs de recrutareFaza 3
- Northwestern Medicine Oak Brook, Oak Brook · La 9 mi distanță
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Hope and Healing Cancer Services, Hinsdale · La 10 mi distanță
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
În curs de recrutareFaza 3
- Advocate Christ Medical Center, Oak Lawn · La 9 mi distanță
- Hope and Healing Cancer Services, Hinsdale · La 10 mi distanță
- Endeavor Health, Elmhurst · La 10 mi distanță
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
În curs de recrutareFaza 2
- Hope and Healing Clinical Research, Hinsdale · La 10 mi distanță
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
În curs de recrutareFaza 3
- Research Site, Hinsdale · La 10 mi distanță
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
În curs de recrutareFaza 3
- Affiliated Oncologists, LLC, Chicago Ridge · La 10 mi distanță
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 3
- Research Site, Hinsdale · La 10 mi distanță
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
În curs de recrutareFaza 2/3
- Loyola University Medical Center, Maywood · La 5 mi distanță
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Hope and Healing Cancer Services, Hinsdale · La 10 mi distanță
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Affiliated Oncologists, LLC, Chicago Ridge · La 10 mi distanță
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
În curs de recrutareFaza 3
- Research Site, Hinsdale · La 10 mi distanță
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Research Site, Hinsdale · La 10 mi distanță
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
În curs de recrutareFaza 3
- Northwestern Medicine Oak Brook, Oak Brook · La 9 mi distanță
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
În curs de recrutareFaza 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · La 10 mi distanță
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · La 3 mi distanță
- Edward Hines Jr VA Hospital, Hines · La 4 mi distanță
- Loyola University Medical Center, Maywood · La 5 mi distanță
- și încă 2
MYLUNG Consortium Part 3: Observational Study
În curs de recrutareStudiu observațional
- Affiliated Oncologists, LLC, Chicago Ridge · La 10 mi distanță
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Edward Hines Jr VA Hospital, Hines · La 4 mi distanță
- Loyola University Medical Center, Maywood · La 5 mi distanță
- Northwestern Medicine Oak Brook, Oak Brook · La 9 mi distanță
- și încă 3
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- Loyola University Medical Center, Maywood · La 5 mi distanță
- Northwestern Medicine Oak Brook, Oak Brook · La 9 mi distanță
- Advocate Christ Medical Center, Oak Lawn · La 9 mi distanță
- și încă 2
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Edward Hines Jr VA Hospital, Hines · La 4 mi distanță
- Loyola University Medical Center, Maywood · La 5 mi distanță
- Northwestern Medicine Oak Brook, Oak Brook · La 9 mi distanță
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- Advocate Christ Medical Center, Oak Lawn · La 9 mi distanță
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · La 9 mi distanță
- Advocate High Tech Medical Park, Palos Heights · La 12 mi distanță
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
În curs de recrutare
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · La 4 mi distanță
GEMINI-NSCLC: NSCLC Biomarker Study
În curs de recrutareStudiu observațional
- Hope and Healing Cancer Services, Hinsdale · La 10 mi distanță
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY121 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH57 studii
- Washington, DC55 studii
Alte studii în Cicero
- Cancer pulmonar17 studii
- Cancer de prostată14 studii
- Cancer (toate tipurile)13 studii
- Cancer de sân11 studii
- Leucemie mieloasă acută11 studii
- Cancer colorectal10 studii
- Cancer de vezică urinară8 studii
- Melanom7 studii
- Boli cardiovasculare7 studii
- Cancer metastatic7 studii
- Mielom multiplu6 studii
- Limfom Burkitt6 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.